TH169587A - Ethyl derivatives that are modulators of MGLUR5 receptor activity. - Google Patents
Ethyl derivatives that are modulators of MGLUR5 receptor activity.Info
- Publication number
- TH169587A TH169587A TH1501002120A TH1501002120A TH169587A TH 169587 A TH169587 A TH 169587A TH 1501002120 A TH1501002120 A TH 1501002120A TH 1501002120 A TH1501002120 A TH 1501002120A TH 169587 A TH169587 A TH 169587A
- Authority
- TH
- Thailand
- Prior art keywords
- syndrome
- formula
- depression
- present
- chemical formula
- Prior art date
Links
- 101150087728 Grm5 gene Proteins 0.000 title 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 title 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 claims abstract 6
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 3
- 208000019901 Anxiety disease Diseases 0.000 claims abstract 2
- 206010003805 Autism Diseases 0.000 claims abstract 2
- 208000020706 Autistic disease Diseases 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract 2
- 208000018737 Parkinson disease Diseases 0.000 claims abstract 2
- 210000001766 X chromosome Anatomy 0.000 claims abstract 2
- 150000008043 acidic salts Chemical class 0.000 claims abstract 2
- 230000003281 allosteric effect Effects 0.000 claims abstract 2
- 230000036506 anxiety Effects 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 150000004673 fluoride salts Chemical group 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 2
- 239000001257 hydrogen Substances 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 2
- 230000002503 metabolic effect Effects 0.000 claims abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 239000003607 modifier Substances 0.000 claims abstract 2
- 230000003287 optical effect Effects 0.000 claims abstract 2
- 150000003431 steroids Chemical class 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
Abstract
การประดิษฐ์ปัจจุบันเกี่ยวข้องกับอนุพันธ์เอธินิล (ethylnyl) ของสูตร I (สูตรเคมี) I ที่ซึ่ง Y คือ N หรือ CH; R1 คือฟลูออไรหรือคลอไร; R2 คือไฮโดรเจนหรือเมธิล; หรือกับเกลือที่เติมกรดที่ยอมรับได้ทางเภสัชกรรม, กับสารผสมราวึมิก, หรือกับอีแนนทิ โอเมอร์ที่สอดคล้องของสิ่งนั้นและ/หรือออพติคัลไอไซเมอรืและ/หรือสเตอริโโซเมอรืของสิ่ง นั้น ในปัจจุบันได้ถูกพบอย่างน่าแปลใจว่าสารประกอบของสูตรทั้วไป I เป็นสารต้านเมตาโบ โทรปิกกลูตาเมตรีเวปเตอร์ (สารปรับอัลโลสเตอริกลบ) สำหรับใช้ในการรับษาอาการกังวล และอากเจ็บปวด, ภาวะซึมเสร้า, กลุ่มเศร้า, กลุ่มอาการโครโมโซม X เปราะบาง, กลุ่มโรคออทิสติก, โรค พาร์กินสัน, และดดรคกรดไหลย้อน (GERD) สิทธิบัตรยา The present invention involves an ethylnyl derivative of formula I (chemical formula) I, where Y is N or CH; R1 is fluoride or chloride; R2 is hydrogen or methyl; Or with a chemically acceptable acidic salt, with a rye mixture, or with an enanthi The corresponding ome of the thing and / or the optical isomer and / or the steroid of that present have been implicitly found that the compound of the whole formula Go I is a metabolic agent. Tropiglutametriwepters (Negative allosteric modifiers) for use in the treatment of anxiety And pain syndrome, depression, depression, fragile X chromosome syndrome, autism syndrome, Parkinson's disease, and acid reflux (GERD) drug patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH169587A true TH169587A (en) | 2017-10-27 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2897615A4 (en) | PHARMACOKINETICS OF FORMULATIONS OF BENZOQUINOLINE INHIBITORS DEUTERATED TO THE VESICULAR MONOAMINE CARRIER 2 | |
| ECSP13012611A (en) | PIRAZOL-AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2 | |
| PH12014501277A1 (en) | Kinase inhibitors | |
| EP2768532A4 (en) | FORMANTS OF STANOLPT STABILIZED WITH SODIUM CHLORIDE | |
| AR100818A1 (en) | N- (CYANOMETIL) -4- (2- (4-MORFOLINOFENILAMINO) PIRIMIDIN-4-IL) BENZAMIDA | |
| CY1118439T1 (en) | NEW AGOMELATIN CYCLES | |
| ECSP15012804A (en) | ALCOXYPYRAZOLES AS SOLUBLE GUANILATE CYCLASE ACTIVATORS | |
| EA201590699A1 (en) | Derivatives of ethylenes as modulators of MGLUR5 RECEPTOR ACTIVITY | |
| PH12014501278A1 (en) | Kinase inhibitors | |
| PH12018550212A1 (en) | Rotigotine behenate and preparation method and use thereof | |
| CU20120087A7 (en) | HYDROCHLORIDE SYNTHESIS AND CRYSTAL FORM OF 4- (3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI) BENZAMIDE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| BR112015002320A2 (en) | ethinyl derivatives as modulators of mglur5 receptor activity | |
| TH169587A (en) | Ethyl derivatives that are modulators of MGLUR5 receptor activity. | |
| EA201590722A1 (en) | DERIVATIVES OF ETHYNES AS MODELS OF ACTIVITY OF METABOTROPIC GLUTAMATE RECEPTOR OF SUBTLE 5 | |
| EA201590415A1 (en) | DERIVATIVES OF DIAZEPINONA APPLICABLE FOR THE TREATMENT OF SYNDROME WITH Fragile X-CHROMOSOME, PARKINSON'S DISEASE OR REFLUX DISEASE | |
| TH167680A (en) | Ethyl derivatives as a modulator of activity of MGLUR5 receptor. | |
| ITTO20110652A1 (en) | COMPOUND DERIVED FROM THE ADENINE HAVING IMMUNO-MODULATING ACTION, ANTI-INFLAMMATORY AND ANTI-DOLUTION ACTION | |
| TH152834A (en) | The derivative [1,2,3] triazolo [4,5-D] pyrimidine is the active agent of the cannabinoid receptor. | |
| PL402331A1 (en) | Method of obtaining melphalan derivatives, derivatives obtained by this method, containing a pharmaceutical agent and medical use | |
| TH160969A (en) | Aryl ethanol derivatives | |
| TH154796A (en) | Kinase inhibitor | |
| TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
| TH169423A (en) | Tetrahydroimmidazo derivatives [1,5-d] [1,4] oxacipine | |
| TH167694A (en) | Ethylenediamin Which is a metabolic glutamate receptor antagonist | |
| TH1501005211A (en) | Elements for the treatment of sleep apnea |